Indinavir (Crixivan) is not recommended for pregnant women, following the observation that pregnant women have substantially reduced concentrations of indinavir in the blood at weeks 30 to 32 of pregnancy. This increases the risk of the development of resistance and treatment failure, as well as mother-to-child transmission of HIV during childbirth.